Search filters

List of works by Nicolas Boissel

A landscape of germline mutations in a cohort of inherited bone marrow failure patients

scientific article published on 16 November 2017

A multiparametric niche-like drug screening platform in acute myeloid leukemia

scientific article published in 2022

Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?

scientific article published on 12 June 2018

Acute myeloid leukemia impairs natural killer cells through the formation of a deficient cytotoxic immunological synapse.

scientific article

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment

scientific article published on 06 August 2020

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial

scientific article

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group.

scientific article published on 22 February 2018

Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype

scientific article published on 30 December 2019

Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy

scientific article published on 24 June 2020

Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study

scientific article published on 20 June 2011

Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis

scientific article published on 12 February 2014

Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion

scientific article published on 5 August 2015

Dexamethasone in patients with acute lung injury from acute monocytic leukaemia ⬇️

scientific article published on August 4, 2011

Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

scientific article published on 01 March 2011

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

scientific article published on 01 October 2002

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations.

scientific article

Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission

scientific article

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.

scientific article published on 8 April 2009

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association

scientific article published on 13 October 2015

Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia.

scientific article published on 31 December 2014

Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria ⬇️

scientific article published on April 1, 2011

Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood

scientific article

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

scientific article published on 20 May 2010

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial ⬇️

scientific article published on January 31, 2012

Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells

scientific article published on 23 January 2007

Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNA

scientific article published on 08 March 2014

Outcome of treatment after first relapse in younger adults with acute myeloid leukemia initially treated by the ALFA-9802 trial

scientific article published on 28 May 2012

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome

scientific article published on 03 December 2018

Postinduction Minimal Residual Disease Predicts Outcome and Benefit From Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia With NPM1 Mutation: A Study by the Acute Leukemia French Association Group.

scientific article

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

scientific article

Pyoderma gangrenosum of the breast: A diagnosis not to be missed ⬇️

scientific article published on September 18, 2010

Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group

scientific article published on 9 October 2015

Significance of herpesvirus 6 in BAL fluid of hematology patients with acute respiratory failure ⬇️

scientific article published on May 3, 2011

Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and older

scientific article

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML.

scientific article published on 16 January 2017

Treatment of Refractory Erdheim–Chester Disease with Double Autologous Hematopoietic Stem-Cell Transplantation

scientific article (publication date: 6 November 2001)

Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association

scientific article

Paulina is supported by:

About Paulina

Help